Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)
USD 0.65
(0.0%)
USD 0.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 195.23 Million | 221.59 Million | 199.54 Million | 169.63 Million | 183.86 Million | 193.35 Million |
| Cost of Revenue | 61.16 Million | 82.58 Million | 57.01 Million | 48.31 Million | 55.42 Million | 57.96 Million |
| Gross Profit | 134.07 Million | 139.01 Million | 142.52 Million | 121.32 Million | 128.43 Million | 135.39 Million |
| Operating Expenses | 55.24 Million | 36.35 Million | 43.72 Million | 38.29 Million | 45.19 Million | 46.49 Million |
| Selling, General and Administrative Expenses | 53.67 Million | 35.37 Million | 42.27 Million | 37.04 Million | 43.45 Million | 44.12 Million |
| Research and Development Expenses | 1.56 Million | 985.54 Thousand | 1.44 Million | 1.22 Million | 1.73 Million | 2.36 Million |
| Other Expenses | - | - | - | -27.08 Thousand | - | - |
| Cost and Expenses | 116.4 Million | 118.94 Million | 100.74 Million | 86.6 Million | 100.61 Million | 104.46 Million |
| Operating Income | 624.14 Million | 102.65 Million | 98.8 Million | 83.03 Million | 83.24 Million | 88.89 Million |
| Interest Expense | 5.97 Million | 596.65 Thousand | 603.57 Thousand | 554.56 Thousand | 539.92 Thousand | 2426.77 |
| Income Tax Expense | 12.44 Million | 17.23 Million | 16.26 Million | 15.22 Million | 14.42 Million | 15.27 Million |
| Earnings before Tax | 88.47 Million | 105.92 Million | 99.77 Million | 88.56 Million | 88.7 Million | 92.07 Million |
| Net Income | 69.18 Million | 82.67 Million | 77.94 Million | 69.95 Million | 71.37 Million | 74.17 Million |
| Earnings Per Share Basic | 0.08 | 0.10 | 0.09 | 0.08 | 0.09 | 0.09 |
| Earnings Per Share Diluted | 0.08 | 0.10 | 0.09 | 0.08 | 0.09 | 0.09 |
| Weighted Average Shares Outstanding | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Gross Margin | 0.69 | 0.63 | 0.71 | 0.72 | 0.70 | 0.70 |
| EBIT Margin | 0.46 | 0.51 | 0.54 | 0.55 | 0.51 | 0.48 |
| Profit Margin | 0.35 | 0.37 | 0.39 | 0.41 | 0.39 | 0.38 |
| EBITDA | 89.4 Million | 112.31 Million | 107.77 Million | 99.19 Million | 93.41 Million | 95.94 Million |
| Earnings Before Tax Margin | 3.20 | 0.46 | 0.50 | 0.49 | 0.45 | 0.46 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 42.54 Million | 42.45 Million | 195.23 Million | 45.59 Million | 45.47 Million | 51.86 Million |
| Cost of Revenue | 13.62 Million | 13.59 Million | 61.16 Million | 11 Million | 10.97 Million | 19.5 Million |
| Gross Profit | 28.92 Million | 28.86 Million | 134.07 Million | 34.58 Million | 34.49 Million | 32.35 Million |
| Operating Expenses | 12.35 Million | 12.32 Million | 55.24 Million | 15.75 Million | 15.76 Million | 11.44 Million |
| Selling, General and Administrative Expenses | 12.6 Million | 12.57 Million | - | 16.1 Million | 16.05 Million | 11.48 Million |
| Research and Development Expenses | - | - | - | 781.7 Thousand | 779.49 Thousand | - |
| Other Expenses | -249.71 Thousand | -249.18 Thousand | 3.65 Million | -1.13 Million | - | - |
| Cost and Expenses | 25.97 Million | 25.91 Million | 116.4 Million | 26.76 Million | 26.74 Million | 30.95 Million |
| Operating Income | 16.57 Million | 16.54 Million | 78.83 Million | 18.83 Million | 18.66 Million | 21.05 Million |
| Interest Expense | - | - | 5.97 Million | 423.65 Thousand | - | 340.48 Thousand |
| Income Tax Expense | 2.77 Million | 2.76 Million | 12.44 Million | 2.63 Million | 2.62 Million | 3.57 Million |
| Earnings before Tax | 18.16 Million | 18.12 Million | 88.47 Million | 21.37 Million | 21.31 Million | 22.58 Million |
| Net Income | 14.07 Million | 14.04 Million | 69.18 Million | 17.56 Million | 17.51 Million | 16.97 Million |
| Earnings Per Share Basic | 0.02 | 0.02 | - | 0.02 | 0.02 | 0.02 |
| Earnings Per Share Diluted | 0.02 | 0.02 | - | 0.02 | 0.02 | 0.02 |
| Weighted Average Shares Outstanding | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Gross Margin | 0.68 | 0.68 | 0.69 | 0.76 | 0.76 | 0.62 |
| EBIT Margin | 0.40 | 0.40 | - | 0.42 | 0.42 | 0.42 |
| Profit Margin | 0.33 | 0.33 | 0.35 | 0.39 | 0.39 | 0.33 |
| EBITDA | 17.17 Million | 17.13 Million | - | 19.26 Million | 19.21 Million | 21.57 Million |
| Earnings Before Tax Margin | 0.39 | 0.39 | 0.40 | 0.41 | 0.41 | 0.41 |
5236
TTMZF
EVKG
BAJAJHCARE
SBFM
7164